type-2

Documents about type-2

• Use of Nutraceuticals in Clinical Practice#148604ClinicalTrials.gov
• Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin#148647ClinicalTrials.gov
• App-based Diabetes Management and Community-based Interventions#152609ClinicalTrials.gov
• A Real World Experience of Dapagliflozin in Type 2 Diabetes#158125ClinicalTrials.gov
• KCNQ1 Antibodies for Immunotherapy of Long QT Syndrome Type 2#159236HAL (France)
• A HR20031 FE Study on Healthy Subjects#172508ClinicalTrials.gov
• Glucophage XR® Observational Study#175067ClinicalTrials.gov
• Arginase Inhibition in Ischemia-reperfusion Injury#180309ClinicalTrials.gov
• Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus#180338ClinicalTrials.gov
• Phase 4 Study in the Elderly Patients With T2DM#181733ClinicalTrials.gov
• Diabetes Discharge Transitional CGM Study (DDT-CGM)#184763ClinicalTrials.gov
• Lifestyle interventions to prevent gestational and type 2 diabetes among migrant women from low- and middle-income countries: a systematic review.#29693PubMed
• Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug Naive#67829ClinicalTrials.gov
• A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM#141135ClinicalTrials.gov
• Application of Artificial Intelligence in Early Detection of Eye Complications in Diabetics#158132ClinicalTrials.gov
• A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease#181667ClinicalTrials.gov
• A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both#181745ClinicalTrials.gov
• Reliable discrimination of type 1 and type 2 diabetes by flow-through leukocyte-endothelium interactions exploiting advanced hydrodynamic detection parameters.#1342NCBI PubMed Central
• A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)#175086ClinicalTrials.gov
• Efficacy and Safety of Henagliflozin Proline and Metformin Hydrochloride Extended-release Tablets (Ⅰ) Versus Metformin Tablets in Patients With New-onset Type 2 Diabetes: a Multicenter, Randomized Controlled Study#152350ClinicalTrials.gov
• A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin#158175ClinicalTrials.gov
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus#158186ClinicalTrials.gov
• The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction#123654ClinicalTrials.gov
• Relation Between Serum Uric Acid and Metabolic Syndrome in Type 2 DM#18748ClinicalTrials.gov
• Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets#28557ClinicalTrials.gov
• Sitagliptin Added-on to Insulin Study (0431-051)#28584ClinicalTrials.gov
• 24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes#121281ClinicalTrials.gov
• Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)#121320ClinicalTrials.gov
• Mechanism of SGLT2 Inhibition in the Kidney#123625ClinicalTrials.gov
• Prospective Study of Patients With Hirsutism#123647ClinicalTrials.gov
• Is Carotid Intima-media Thickness Affected by A1C Variability?#126022ClinicalTrials.gov
• Effect of Sitagliptin on Postprandial Lipoprotein Metabolism#126024ClinicalTrials.gov
• Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus#127764ClinicalTrials.gov
• Liraglutide Use in Prader-Willi Syndrome#136214ClinicalTrials.gov
• A Two Part Study of Peroral Insulin in Type 2 Diabetes#146426ClinicalTrials.gov
• Ezetimibe and Simvastatin in Dyslipidemia of Diabetes#148667ClinicalTrials.gov
• Dose-Range Finding Study for MK0893 (0893-008)#148699ClinicalTrials.gov
• The Interaction Between Metformin and Physical Training#152346ClinicalTrials.gov
• The Poor Responders Study#152572ClinicalTrials.gov
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure#158142ClinicalTrials.gov
• Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects#162398ClinicalTrials.gov
• Metformin And Cardiovascular Effectiveness vs SGLT2 (MACES)#180300ClinicalTrials.gov
• Finding the Patient's Voice Diabetes Prevention Programs#180308ClinicalTrials.gov
• Effects of Colesevelam HCl On Bile Acid Kinetics#181697ClinicalTrials.gov
• The Copenhagen Insulin and Metformin Therapy Trial#184766ClinicalTrials.gov
• Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes#125983ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before#127787ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin#160258ClinicalTrials.gov
• DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes#162348ClinicalTrials.gov
• Evaluating GLP-1 Receptor Agonist in the Treatment of Type 2 Diabetes: A Comparison of Medication Efficacy and Cost#183365BYU ScholarsArchive